Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Green light for phase I/II study of Enzo's gene vector for HIV

Nov. 10, 2003

IR-103 enters preclinical development program for HIV

Nov. 5, 2003

AIMECS 03 news: di- and tripeptide HIV-1 protease inhibitors with potent antiviral activity

Nov. 4, 2003

Boehringer Ingelheim patent covers new HIV RT inhibitors

Nov. 4, 2003

Tripep identifies new candidate drug for HIV

Nov. 3, 2003

SOLO Lexiva results show increase in HDL cholesterol in treatment-naive HIV patients

Oct. 31, 2003

European approval announced for Emtriva

Oct. 31, 2003

Novel HIV integrase inhibitors claimed by Merck

Oct. 30, 2003

Dyax and URRMA enter alliance to develop anti-R7V antibodies for HIV

Oct. 27, 2003

Novel HIV protease inhibitors developed by U. of Illinois researchers

Oct. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...